I think the problem is it's flying under the radar due to its low market cap and the fact that glaucoma is not a popular area to invest in for the ASX get rich quick crowd.
The next potential catalyst is the audited results in August, I'm really hoping they give a further sales update as I suspect it will be good & hopefully give the SP a decent boost over 30c
CMS Proposes Major Increase in Reimbursement for Canaloplasty, page-178
-
- There are more pages in this discussion • 330 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EYE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
21.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $48.10M | |||
| Open | High | Low | Value | Volume |
| 21.0¢ | 22.0¢ | 20.0¢ | $89.91K | 431.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 63999 | 21.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.5¢ | 97558 | 1 |
View Market Depth
| Last trade - 16.10pm 02/09/2024 (20 minute delay) ? |
| EYE (ASX) Chart |